Ken Griffin Bausch Health Companies Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 3,603,900 shares of BHC stock, worth $24.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,603,900
Previous 3,346,000
7.71%
Holding current value
$24.5 Million
Previous $26.8 Million
42.49%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding BHC
# of Institutions
281Shares Held
278MCall Options Held
21.5MPut Options Held
21.8M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$236 Million3.29% of portfolio
-
Goldentree Asset Management LP New York, NY27.6MShares$188 Million23.66% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$180 Million20.29% of portfolio
-
Franklin Resources Inc San Mateo, CA15.9MShares$108 Million0.06% of portfolio
-
National Bank Of Canada15.7MShares$106 Million0.29% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.46B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...